OTC/Dietary Supplement Combos Cited In FDA Warning Letters
This article was originally published in The Tan Sheet
Executive Summary
The presence of acetaminophen in OTC/dietary supplement combination products renders them drugs, FDA says in recent warning letters to two companies.
You may also be interested in...
Will Bayer Supplement-Drug Combo Draw Other Firms Into New Market?
FDA's silence about Bayer's launch of Aspirin with Heart Advantage could speak volumes about a possible new marketing opportunity
Will Bayer Supplement-Drug Combo Draw Other Firms Into New Market?
FDA's silence about Bayer's launch of Aspirin with Heart Advantage could speak volumes about a possible new marketing opportunity
Will Bayer Supplement-Drug Combo Draw Other Firms Into New Market?
FDA's silence about Bayer's launch of Aspirin with Heart Advantage could speak volumes about a possible new marketing opportunity